Skip to main content
. 2021 May 10;12(6):996–1004. doi: 10.1021/acsmedchemlett.1c00155

Figure 6.

Figure 6

Antitumor activity of SD-91 in the MOLM-16 xenograft model in mice. SCID mice bearing the MOLM-16 tumors were treated with SD-91 at the indicated dosing schedules were treated at the indicated dosing schedules, and tumor volumes (A) and mice body weight (B) were measured every 2 days.